Soligenix Inc.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Soligenix Inc.
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
SNGX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0000812796

Board of directors

Follow this board

Chief executives

Christopher J. Schaber · CHAIRMAN, CEO AND PRESIDENT
Dates unknown

Board connections

3 of this board's directors also sit on 5 other boards.

Network of Soligenix Inc.'s board connections Celularity Inc. Celularity Inc. Kura Oncology Inc. Kura Oncology Inc. NexGel Inc NexGel Inc PTC Therapeutics Inc. PTC Therapeutics Inc. Rigel Pharmaceuticals Inc. Rigel Pharmaceuticals... Anthony Gregg Lapointe Anthony Gregg Lapoin... Diane L. Parks Diane L. Parks Jerome B. Zeldis Jerome B. Zeldis Soligenix Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$19,974
1 purchase by 1 insider
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Oct 2, 2025 Christopher J. Schaber Director, Officer (CHAIRMAN, CEO AND PRESIDENT) Open-market purchase +15,132 $1.32 $19,974

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.